Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Why don't you run that theory by the new BIEL Partner once BIEL can 'name Names'
Just proof that BIEL has an agreement with SAI or they wouldn't be Tweeting about an SAI 'Powered by ActiPatch' Product.
Don't forget SAI and their 10 'Powered by ActiPatch' Products
If you add up the 'Sample Display' from their Planogram you get 66 Devices.
If SAI's opening order is for just 500 stores that comes to 33,000 devices.
SAI's Launch should indicate the return to a healthy supply chain for BIEL.
https://imgur.com/a/fuarFfh
https://imgur.com/a/xeoTjm5
BIEL acknowledged an SAI deal last year.
More orthopedic compression supports POWERED BY @ActiPatch hitting the market. #innovation #actipatch #teambiel #drugfreepainrelief pic.twitter.com/fXGzG0NuSM
— BioElectronics Corporation (@BielCorp) February 26, 2021
LOL, Thanks for providing more data to prove my Point
<<<<<<< Raw Materials on the Q2 statement were only $4,416 and on the Q1 statement raw materials were $19,583 >>>>>>>
You are aware that the Chip Shortage started in 2020 right?
Q1 2021 and Q2 2021 were right in the middle of the shortage.
Supply is slowly coming back hence KT Tape's willingness to expand into the UK, Estonia, Latvia, Lithuania over the last few months.
2020–2022 global chip shortage
The 2020–2022 global chip shortage is an ongoing crisis in which the demand for integrated circuits (commonly known as semiconductor chips) is greater than the supply, affecting more than 169 industries[3] and has led to major price increases, shortages and queues amongst consumers for automobiles, graphics cards, video game consoles, computers, and other products that require semiconductors.[4][5][6] Commonly cited causes for the shortage include the COVID-19 pandemic, the China–United States trade war, and various severe weather incidents.
https://en.wikipedia.org/wiki/2020%E2%80%932022_global_chip_shortage
Why the Chip Shortage is Lasting so Long, and What Industry Leaders Can Do About It Dec 22nd, 2021
On Feb. 24, 2021, then newly-elected President Joe Biden signed an executive order aimed to address a worldwide shortage of semiconductors that has impacted industries ranging from automotive, medical supplies, consumer electronics and even machinery.
That was 10 months ago, and the chip shortage is still firmly hindering those same markets. While some aspects of the semiconductor supply chain have improved, various estimates put the shortage lasting well into 2022.
https://www.manufacturing.net/supply-chain/blog/21965187/why-the-chip-shortage-is-lasting-so-long-and-what-industry-leaders-can-do-about-it
One Important Organ, 4 new potential Indications for RecoveryRx
Eyes maintain a healthy vision through balanced blood flow and eye pressure. Iris and pupil monitor light passing through the cornea. This light falls on the retina. The retina contains photoreceptor cells, rods, and cones. These cells perform the crucial task of Photo transduction, converting light into electric signals and send them to the brain through the optic nerve.
Any obstruction in the path of light or its detection results in poor vision. It regulates micro-circulation in the eye, reduces inflammation, and facilitates self-regeneration in nerves. PEMF supports wound healing, cellular metabolism, and cell proliferation. So it can also cure the root causes of eye diseases which are diabetes and hypertension.
PEMF Therapy for Cataract
A cataract is a condition when there is an accumulation of some protein or pigment on the lens. So there is less transmission of light on the retina, causing blurriness, cloudiness of lens, and scattering of light. PEMF can help to cure and prevent cataracts in the following ways.
Increasing microcirculation in eye
Reducing oxidative stress
Maintaining the flow of fluids and nutrients
and reducing pigment accumulation on lens
PEMF for Glaucoma
Damage to the optic nerve results in glaucoma. Aqueous humor is a fluid that maintains the pressure and shape of the eye. It facilitates the transportation of nutrients in and of pathogens out of the eye. At the base of the cornea and iris lies the drainage network of an eye. A minor blockage in the drainage network (open-angle glaucoma) builds up pressure on the optic nerve. A major obstruction in the drainage network (closed-angle glaucoma) leads to loss of vision. PEMF can be helpful in the following ways.
Improves circulation in eyes and smooth flow of aqueous humor
Restores natural pressure of the eye
Unblocks drainage network by reducing edema
Regenerates nerve fibers and neurons
PEMF for Macular Degeneration
Macular degeneration is the distortion in vision that occurs due to the gradual degeneration of cone cells in the macula. The condition leads to poor image detection. The macula is a small area in the middle of the retina. The major factors are mitochondrial dysfunction, hypertension, obesity, high cholesterol. The accumulation of cellular debris in the macular causes damage to the photoreceptors cones. Certain PEMF systems are available in the market having special features to reverse the condition. It prevents the progression of macular damage by
Regenerating neural tissues
Enhances removal of wastes
Increases oxygenation reducing oxidative stress
Improves cellular metabolism and cures mitochondrial dysfunction
PEMF and Retinitis Pigmentosa
Retinitis pigmentosa is a genetic disorder of the eye in which there is a supply of irrelevant protein to the retina. Rods cells are abundant in the outer layer of the retina. They detect light in a dim environment. The disease causes damage to rods; as a consequence, and the patient starts losing night and peripheral vision. The damage starts accessing the cones and results in the initiation of day-time vision-loss. Researches prove that PEMF results in improved visual performance in RP patients as
Improves the light sensitivity of patients
Treats the choroid ischemia (reduced supply of blood choroid)
Reverses cells degeneration
Enhances ATP production to provide energy to cells
Initiates nerve sprouting
PEMF machines are safe to use for sensitive parts like the eyes. You can choose any device depending on your condition. Many light-weight, handy devices available in various forms as patches or even PEMF glasses.
Besides eye diseases, PEMF therapy for the eyes provides an easy, painless, economical, and time-saving solution for overall eye health.
https://sciencebusiness.technewslit.com/?p=41255
It must be difficult when the Facts don't align with one's agenda
But that does not make the Facts incorrect it makes the agenda based on Opinions not Facts.
Let me help you with your DD:
Google, 'Covid Supply Chain Shortage', 25 million results
Google, 'Covid Chip Shortage', 18 million results
Google, 'Covid Labor Shortage', 37 million results
<<<<<<<<<<< "Only one of BIEL's OEMs, KT Tape, is doing much promotion, still not 100%" -- my point exactly.
"Scott/DonJoy is probably at one tenth of KT's promotion effort" -- my point exactly.>>>>>>>>>>>>
The Point is that there is no reason to mount an advertising campaign that will create demand for 1 million units if you can only get 100,000 units to sell. Business 101
<<<<<<<<< Yes, examine the facts: the financial statements. >>>>>>>>>
Q3 2021 BIEL Financial Statement page 14,
Raw Materials - $44,505
BIEL's average 'Raw Materials' over the last 10 years has been $298k.
With demand for devices at the highest level since the 2015-2017 UK Boots/Lloyds period why would BIEL only have 15-20% of the 'Raw Materials' that they held during that 2015-2017 period?
Answer, Covid Chip Shortage.
Pretty simple, if you can't get enough 'Raw Materials' you can't make enough Devices.
Check in with Ford, Hyundai, Honda dealers to confirm. My 2018 SUV is currently worth $5,000 more than I paid for it. Why, Covid Chip Shortage is making new cars hard to get which has increased the value of used cars.
Thanks GG, BIEL Spending $$$$ on Researchers and Whse Expansion
BIEL can't "name Names" yet so they are leaving clues.
Get a Clue!
Pretty obvious if one examines the facts
<<<<<< KT Tape and DonJoy aren't doing enough to promote or advertise their ActiPatch products >>>>>>
* Only one of BIEL's OEMs, KT Tape, is doing much promotion, still not 100%
* Scott/DonJoy is probably at one tenth of KT's promotion effort
* SAI, after planning a 3/2021 Launch, did not launch at all in 2021
* Auto, Gaming, Computers, Medical Devices have all had to reduce/suspend production due to covid caused Chip/Labor/Transport disruptions
* BIEL's 'Raw Materials' in Q3 2021 were down to $44k, they have been as high as $574k over the last 10 years
Those are the facts.
Does anyone really think that BIEL would not have the same issues as other manufacturers?
Does anyone think that KT or DonJoy would spend $500k on a new Product Launch with no guarantee of Product availability?
The good news is that it takes a lot fewer Chips to produce an ActiPatch than a Car or Computer.
KT's recent expansion in Europe, Scott's/DonJoy and SAI's renewal of their 2022 'FDA Establishment Registration' are all good signs that 2022 will bring BIEL greater Production Capacity, OEM Promotion and Sales Revenue.
Neglecting to mention the KT Wave Introduction that happened in February
KT Timeline:
12/11/2020 KT Health files Patent Application for the KT Recovery+ Wave
https://uspto.report/TM/90376306
Dec. 15, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioElectronics Corporation (OTC PINK: BIEL), (www.bielcorp.com) is pleased to announce that it has executed an OEM agreement with KT Health, LLC to bring its innovative pain management devices to encompass retail and e-commerce distribution throughout North America, as well as several additional key international markets.
https://www.globenewswire.com/news-release/2020/12/15/2145223/0/en/BioElectronics-Executes-Distribution-Agreement-with-KT-Health-LLC-for-North-American-Retail-Market.html
2/2021 - The Reddit factor - " $BIEL - This should NOT be a pennystock; Right tech, Right partnership; BIG WIN! An overlooked and underestimated catalyst to propel the company's revenue to significant all-time highs, is its recent partnership with KT-Tape to establish the company's feet in SPORTS MEDICINE. KT and BielCorp have reached an agreement as follows: The agreement incorporates BioElectronics’ ActiPatch technology into KT Health’s KT Recovery+ product line, which will be marketed under the proprietary trade name KT Recovery+ Wave. KT Health will leverage BioElectronics’ FDA 510(k) clearance to market, promote, and distribute the devices for the treatment of general musculoskeletal pain."
https://www.reddit.com/r/PennyStocksDD/comments/lp35fp/biel_this_should_not_be_a_pennystock_right_tech/
2/17/2021 Amazon begins KT Wave Sales
https://www.amazon.com/KT-Tape-Recovery-Electromagnetic-Relief/dp/B08WTN6V2Y
Feb 22, 2021, 10:34 /PRNewswire - KT Tape Launches KT Recovery+ Wave
Newest pain relief product miniaturizes pulsed shortwave therapy
KT Tape®, a leader in drug-free pain relief, today announced the latest innovation in its recovery product line up: KT Recovery+ Wave™ (KT Wave™). KT Wave is a clinically proven and FDA cleared wearable device that brings the powerful electromagnetic technology traditionally only found at a clinician's office straight to your home in a convenient, wearable, on-the-go solution. With more than 50 percent of Americans experiencing persistent musculoskeletal pain, KT Wave is the perfect solution to provide drug-free pain relief for sports injuries, knee pain, arthritis, back pain, carpal tunnel, sprains and more.
https://www.prnewswire.com/news-releases/kt-tape-launches-kt-recovery-wave-301232376.html
KT Recovery+ Wave Technology Video
4,617 views Feb 22, 2021
15 million Bite out of the 11s at 9:44
.001 Bid up to 50 million size.
Go BIEL !!!
28 mil on the .001 Bid
Zero Trades in the first 5 minutes.
11 Ask now down to 2.9 million.
Placed in the Circular File with the SalesTrac Rubbish ....
The Andy told me Rubbish
The RS any day Rubbish
The BK any day Rubbish
The SEC will close down BIEL Rubbish
The BIEL will never get FDA Clearance Rubbish
The BIEL will never get CE Mark Rubbish
The BIEL will never get an OEM Partner Rubbish
The BIEL will never get FDA Reclassification Rubbish
Geeezzzzz, we are going to need more Circular Files!
Thanks aces, two more likely additions to the Research Team that will put RecoveryRx on the map.
Dr. Benjamin Brucker, Cornell, UPENN, NYU
Dr. W. Stuart Reynolds, Princeton, UPENN, Vanderbilt
I don't think that is what the FB statement said aces
<<<<<<<<< They said no updates till they land the deal >>>>>>>>>>
KW responded to this question,
"Have any other info or updates to shareholders?"
KW response,
"Nothing major....lots of activity going on with finding and recruiting researchers to prove efficacy for wound care/wound pain/phantom limb pain, overactive bladder....ect. When we can name names we will."
"Nothing major", this relates to what she can tell shareholders today not that there is no major event for BIEL.
"When we can name names we will", another reference to what she can't tell shareholders today.
Signed Deals come with conditions and one of those is when the Deal will be released to the public.
"recruiting researchers to prove efficacy", does anyone really think that BIEL can afford to run 4 Clinical Trials hiring outside researchers???
IMO, this is significant circumstantial evidence that BIEL has an agreement with someone and that someone wants to expand the indications for RecoveryRx.
Wise advice PH,chasing a hot penny stock is no fun, been there done that
<<<<<<<<< Nobody wants to be left out of big news >>>>>>>>>
BIEL has had two Billion + share trading days.
1.4 billion shares traded on 2/6/2017 on PR of FDA OTC Knee/Foot Clearance.
1.2 billion shares traded on 2/21/2014 on PR of FDA PSWT Reclassification.
In 2014 the volume had hit 500 million shares in the first 30 minutes of trading.
That is an average of 16.666 million shares every minute.
Trying to get your order filled in that chaos is an exercise in frustration.
What part of 'BIEL does not have the resources to Market/Distribute ActiPatch to the 50 States/330 million people of the US' is so hard to comprehend?
That's why they went to the OEM model.
The OEM Parter Promotes the Product.
The OEM Partner Distributes the Product.
The OEM Partner Pays the 'Slotting Fees' for Retail Shelf Space.
The OEM Partner Handles 'Customer Service' Issues.
BIEL Receives a Purchase Order, Manufactures the Product, Collects a Check.
RecoveryRx is the Medical Professional Product
<<<<<<<<< ActiPatch full body FDA clearances wasn't good enough >>>>>>>>>
Clearances are needed for each 'Medical Condition' that RecoveryRx is to be prescribed for.
The up side is that RecoveryRx has a much higher profit margin than ActiPatch.
Many OEM products make no mention of the manufacturer as the selling company wants the product seen by consumers as 'their product'.
<<<<<<< Take a look at the KT deal. Do you see a BIEL name on that product? >>>>>>>
BIEL was fortunate when Scott/DJO and SAI went with 'Powered By ActiPatch'.
<<<<<<< The U.S. Market was ours for the taking since our first partial approval >>>>>>>
BIEL attempted to market the ActiPatch in the US but did not have the resources to fund a national marketing/distribution campaign.
Look at the Financials from 2015, 2016, 2017, when BIEL had ActiPatch on thousands of UK shelves. Biggest Sales in BIEL's history but also the biggest 'Total G&A Costs' and biggest 'Net Loss'.
This is why BIEL went to the OEM business plan, letting companies with recognized brand names and established distribution networks handle the selling/distribution.
2015 - Sales $2.339 mil - G&A expense $3.128 mil - Net Loss $2.450 mil
2016 - Sales $2.089 mil - G&A expense $2.658 mil - Net Loss $2.106 mil
2017 - Sales $1.763 mil - G&A expense $2.358 mil - Net Loss $2.118 mil
Compare the above numbers to the first 9 months of 2021 under OEM.
2021 - Sales $1.427 mil - G&A expense $871k - Net Loss $162k
(9 month)
ninaaa, there will be several differing Opinions on Kelly's post
I am willing to take it at face value.
BIEL is hiring experts in their field to gain 4 new FDA Indications:
Wound Care
Wound pain
Phantom limb Pain
Over Active Bladder
These are RecoveryRx Indications.
BIEL does not have the resources, on its own, to fund this endeavor.
BIEL has a Partner, Sponsor, Investor, or whatever you want to call it, funding this project.
This will cost millions of dollars and take years to complete so whoever is providing the funds has made a long term commitment to expanding BIEL's product line.
IMO, this is excellent news for shareholders coming from BIEL until they can divulge more details.
Thanks Pro, Not the statement from BIEL I was expecting but....
The question I have is, where is the large amount of $$$$$ coming from for all of this 'Research'?
Research is expensive.
Clinical Trials are expensive.
BIEL currently does not have enough cash to bring a product to market for one of these 4 medical conditions;
Wound Care
Wound pain
Phantom Limb Pain (this is Dr Ilfeld's area of expertise)
Overactive Bladder
ect.
let alone all of them, plus what ever the 'ect' entails.
IMO, this is the question everyone should be pondering, Who is funding all of this 'Research'?
7. To qualify for Current Information on an ongoing basis, companies must:
• Upload reports through OTCIQ on the following schedule:
o Quarterly Report within 45 days of the quarter end
o Annual Report within 90 days of the fiscal year end
o Attorney Letter within 120 days of the fiscal year end.
Thanks AH, KT's Oksana Masters #4 on,'50 Bad Ass Women'
Oksana Masters
@OksanaMasters
OOHHH MY GOODNESS I am BLOWN away to find out @instylemagazine named me in their “50 Bad Ass Women List” alongside such legends, my idols and strong women Two heartsFlexed biceps
Thank you InStyle Magazine for naming me #4.
Feb2022
@InStyle
Badass 50 will be on newsstands Friday
#TeamUSA
https://twitter.com/OksanaMasters/status/1481359766706278400/photo/1
https://www.instyle.com/politics-social-issues/badass-women/badass-50-february-2022
"Wave electromagnetic pain device has really helped!"
Tweet
@mark_denzin
Took a spill on my bike and banged up my shoulder but this
@KTTape @BielCorp Wave electromagnetic pain device has really helped! Go pain free without drugs!
https://twitter.com/mark_denzin/status/1413623513492099077
https://twitter.com/mark_denzin
Executive Director at Alzheimer's Association has several Posts on BIEL
https://www.linkedin.com/in/mark-denzin-8b48b813/
https://www.linkedin.com/in/mark-denzin-8b48b813/detail/recent-activity/
Yep JGD, 10 ActiPatch Enhanced Products
2210 / ActiPatch Trial Device
2211 / ActiPatch Kinesiology Tape
2212 / ActiPatch Replacement Device
2213 / ActiPatch Lower Back Wrap
2214 / ActiPatch Shoulder Wrap
2215 / ActiPatch Compression Knee Sleeve
2216 / ActiPatch Compression Ankle Support
2217 / ActiPatch Plantar-Fasciitis Support
2218 / ActiPatch Wrist Support
2219 / ActiPatch Elbow Support
All 'Powered By ActiPatch'
Check out the SAI Planogram and do the math.
https://imgur.com/a/fuarFfh
https://imgur.com/a/xeoTjm5
https://imgur.com/a/y4t1Zdh
https://imgur.com/a/sxHvVIz
https://imgur.com/a/m4iySis
https://imgur.com/a/N3GA6Wj
https://saibrands.com/
Correct TP, new tech takes some time/money in consumer education to make consumers comfortable in using the product, especially true for a medical device.
Having major brands like KT, DonJoy, and soon SAI with products on the market will help significantly with consumer acceptance.
Looking for some fireworks next week.
To quote pinhigh, "Don't Take Your Eyes Off BIEL".
Time to get current on the effect of Covid on business
<<<<<<<<< Pandemic, that ones getting old >>>>>>>>>>>>>
Companies can't get enough Chips to make their Products.
There are shortages in many products that use integrated circuits due the Pandemic's disruption to the supply chain. Yes, it is still going on 2 years into the Pandemic.
NYT By Neal E. Boudette
Dec. 22, 2021
When Rachael Kasper started shopping for a new car in August, she had her heart set on a Ford Escape plug-in hybrid. The problem was that Ford hasn’t made many of them this year because of a computer chip shortage that has slowed auto production around the world.
The shortage of computer chips, in large part caused by decisions made in the early days of the pandemic, has rippled through the auto industry this year. Manufacturers have had to close plants for lack of parts, leaving car dealers with millions fewer vehicles to sell.
https://www.nytimes.com/2021/12/22/business/economy/car-chip-shortage-pandemic.html
Wired WILL KNIGHT BUSINESS 11.12.2021
Why the Chip Shortage Drags On and On
THE SEMICONDUCTOR INDUSTRY lives at the cutting edge of technological progress. So why can’t it churn out enough chips to keep the world moving?
Nearly two years into pandemic-caused disruptions, a severe shortage of computer chips—the components at the heart of smartphones, laptops, and innumerable other products—continues to affect manufacturers across the global economy.
Automakers have been forced to halt production in recent months as sales decline because they can’t make enough cars. The shortage has affected industries from game consoles and networking gear to medical devices. In October, Apple blamed chip scarcity for crimping its financial results, and Intel warned that the drought will likely stretch to 2023.
https://www.wired.com/story/why-chip-shortage-drags-on/
Wow, major companies can't get enough Chips to make their products. Who else uses Chips in their product? Oh yeah, BIEL does.
Breaking News, AW is no longer running BIEL
All the events mentioned were on AW's watch.
New BIEL Management has made great progress toward BIEL solvency and all these achievements under the dark cloud of the worst pandemic in 100 years:
* BIEL's Goal since 2002 Reached, FDA OTC Musculoskeletal Pain Relief Clearance
* KT Tape OEM Partner
* OEM Product on the shelves of Target & CVS
* KT US Partnership expanded to UK, Australia, Estonia, Latvia, Lithuania
* Scott/DonJoy OEM Partner
* First 12 months of OEM Sales, 10/2020-9/2021 = $1.949 million
* CE Mark for ActiPatch & RecoveryRx
* MDSAP Regulatory Approval
* First Profitable Quarter in BIEL's History, Q3 2021
Monday Morning Quarterbacks love to complain and point out what should have happened.
A whole different game than running a business in Real Time.
The odds are for a 1/19 Substantive PR with 2021 Revenue
Only 6.2 million on the 14 Ask.
Only 900k Shares Available on the 13 Ask
11.7 million shares on the 12 Bid.
Get them now or you will be paying 14.
Buys = 7.3 million shares
Sells = 1 million shares
Reminder, Market closed on Monday.
Nope, BIEL has been working hard to make BIEL successful
While the 'Baloney Vendors' have been hard at work trying to destroy BIEL
Hard work produces:
5 FDA Clearances
OEM Partnerships
International Distribution
CE Mark for both ActiPatch & RecoveryRx
MDSAP Regulatory Approval
$2.25 million in loan interest savings
Baloney consists of:
Fantasy SalesTrac
BIEL to declare BK any day
SEC is going to halt BIEL
The stocks finished
RS any day now
Andy told me
LOL, That's been said multiple times every year for the last 12 years
<<<<<<<<< the stocks finished >>>>>>>>>>
Always Wrong.
12 years of Pure Unadulterated Baloney.
New ActiPatch Video Out with Slovenia Hockey Star Ivo Jan
Better Let the CEO of OTC Markets Know that he has No MMs
**** All Market Makers are Brokers, but not all Brokers are Market Makers, MMs commit to always making a Bid/Ask SP available on the stocks that they cover ****
OTC Markets CEO Explains How The OTC Markets Work
July 20, 2021
In a recent blog post, Cromwell Coulson, president and CEO of OTC Markets Group, the company that operates the regulated electronic market where SEC-registered, FINRA-member broker-dealers can trade OTC securities, explained how the market works.
OTC Trading
Trading on the OTC Markets simply means a security is traded directly between competing broker-dealers rather than trading through a centralized exchange. These broker-dealers, who buy and sell on behalf of clients, will publicize quotes for a specific security.
Competing broker-dealers or ‘market makers’ display the price at which they are willing to buy (the bid) a security and the price at which they are willing to sell (the ask). “Industry-leading market makers, such as Citadel, GTS, Jane Street, StoneX, Susquehanna/G1X and Virtu Financial (NYSE: VIRT), make up the diverse community of 90+ regulated broker-dealers providing continuous liquidity and execution services for investors,” Coulson said.
https://www.yahoo.com/now/otc-markets-ceo-explains-otc-161225536.html
Pick your 5 Favorites pinhigh:
<<<<<<<<<<<< I hope Biel has plans to knockout 5 more! >>>>>>>>>>>>>
Migraine
Diabetic Neuropathy
Overactive Bladder
Chronic Wounds
Depression
Chronic Venus Ulses
Menstrual Pain
Blood Pressure Regulation
Scent Recovery
Vulvodynia
Thanks for the Technical Analysis PT
But news of the new Partner(s) is going to propel BIEL many ticks past .0012 and .0022 very soon, as in don't take your eyes off BIEL!
13s are Printing, Up 18%
Buys = 23 million
Sells = 5 million
Thanks NI, anyone who was concerned about Sree's departure can rest easy
* Sree still Holds BIEL stock
* Wants BIEL to achieve the Success that it Deserves
* Feels BIEL is on the Right Path
* Still available to Advise BIEL
This was an amicable separation.
Buys = 18 million shares
Sells = 3 million shares
Go BIEL !!!
I would say McDavid goes well beyond 'pleasant' Hawk, Great Find!
Today, McDavid products top the recommendation lists of pro athletes, sports medicine professionals and athletic trainers. From our research-backed ankle braces to compression shorts with patented technology, McDavid products address both the broad range and the specific needs of professional - and every day - athletes across a variety of sports.
GLOBAL DISTRIBUTION
The McDavid brand is proudly sold in major sporting good retailers across the United States and over 65 nations worldwide. McDavid is also available at 24/7, online.
Those folks at KT Tape are burning the midnight oil in their World Wide expansion of The Wave.
Go BIEL !!!
Go KT Tape !!!
https://www.mcdavid.com.my/v2/Official/BrandStory
Time for a BIEL History Lesson
<<<<<<< Um, actually, not they proved themselves unskilled for many years until they finally got it right (re 510k Clearance) >>>>>>>
Up until 2015 the FDA had 'Diathermy, Shortwave, For Use Other Than Applying Therapeutic Deep Heat' devices incorrectly in the Class 3 group of devices.
Class 3 devices are largely 'Life Sustaining' devices that deserve the highest level of review because patient's lives depend on them.
BIEL only received 1 FDA Clearance, Prescription Only for Eye Lid Surgery, through 2015 because the FDA did not understand PEMF and its 'mechanism of action'.
It took years of Lobbying the FDA, by BIEL and other parties involved in PEMF, to get PEMF devices Reclassified to a Class 2 status, which reduces the regulatory protocol.
BIEL was instrumental in getting a new FDA Product Code, PQY, 'Nonthermal Shortwave Therapy Device Indicated For Over The Counter Use For The Treatment Of Pain'. To date, 6 years later, ActiPatch is the only device FDA Cleared under the OTC 'PQY' Product Code.
This Reclassification was finalized on 10/13/2015. In January of 2017 the ActiPatch had 2 new OTC Indications, OA of the Knee and Plantar Fasciitis.
In June of 2019 RecoveryRx received FDA Clearance for Postoperative Pain.
In January 2020 of ActiPatch received FDA OTC Clearance for Musculoskeletal Pain. Pain relief for every Muscle, Joint, Tendon and Bone in the body is FDA Cleared.
Musculoskeletal Pain is the wide ranging Clearance that started bringing in the Partners. KT Tape, Scott/DonJoy, SAI, and many more to come.
Thanks for the PM Walker, something big is going down, hopefully shareholders get filled in soon.